Beneficial Role of Vitamin D on Endothelial Progenitor Cells (EPCs) in Cardiovascular Diseases

키워드

참고문헌 (142)

1. Asahara T, "Isolation of putative progenitor endothelial cells for angiogenesis", Science, 275, pp.964~967 (1997)
2. Naeem Z, "Vitamin D deficiency- an ignored epidemic", Int J Health Sci (Qassim), 4, pp.V~VI (2010)
3. Holick MF, "Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease", Am J Clin Nutr, 80, pp.1678~ (2004)
4. Grimes DS, "Sunlight, cholesterol and coronary heart disease", QJM, 89, pp.579~589 (1996)
5. Danik JS, "Vitamin D and cardiovascular disease", Curr Treat Options Cardiovasc Med, 14, pp.414~424 (2012)
6. Schröder-Heurich B, "Vitamin D improves endothelial barrier integrity and counteracts inflammatory effects on endothelial progenitor cells", FASEB J, 33, pp.9142~9153 (2019)
7. Hammer Y, "Effect of vitamin D on endothelial progenitor cells function", PLoS One, 12, pp.e0178057~ (2017)
8. Ai S, "Reduced vitamin D receptor on circulating endothelial progenitor cells : a new risk factor of coronary artery diseases", J Atheroscler Thromb, 25, pp.410~421 (2018)
9. Bozic M, "Impaired vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay : implications for atherosclerosis development", PLoS One, 10, pp.e0136863~ (2015)
10. Aragona CO, "Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease", Stem Cells Int, 2016, pp.8043792~ (2016)
11. Peplow PV, "Growth factor-and cytokine-stimulated endothelial progenitor cells in post-ischemic cerebral neovascularization", Neural Regen Res, 9, pp.1425~1429 (2014)
12. Fadini GP, "Circulating stem cells and cardiovascular outcomes : from basic science to the clinic", Eur Heart J, 41, pp.4271~4282 (2020)
13. Lee PS, "Endothelial progenitor cells in cardiovascular diseases", World J Stem Cells, 6, pp.355~366 (2014)
14. Zheng H, "Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha", CXCR4 via PI3K, eNOS signal transduction pathway, pp.J Cardiovasc Pharmacol, 2007[DOI]
15. Yamaguchi J, "Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization", Circulation, 107, pp.1322~1328 (2003)
16. Natori T, "G-CSF stimulates angiogenesis and promotes tumor growth : potential contribution of bone marrow-derived endothelial progenitor cells", Biochem Biophys Res Commun, 297, pp.1058~1061 (2002)
17. Kalka C, "Vascular endothelial growth factor(165)gene transfer augments circulating endothelial progenitor cells in human subjects", Circ Res, 86, pp.1198~1202 (2000)
18. Thum T, "Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes", Diabetes, 56, pp.666~674 (2007)
19. Medina RJ, "Molecular analysis of endothelial progenitor cell(EPC)subtypes reveals two distinct cell populations with different identities", BMC Med Genomics, 3, pp.18~ (2010)
20. Gulati R, "Diverse origin and function of cells with endothelial phenotype obtained from adult human blood", Circ Res, 93, pp.1023~1025 (2003)
21. Mukai N, "A comparison of the tube forming potentials of early and late endothelial progenitor cells", Exp Cell Res, 314, pp.430~440 (2008)
22. Patel RS, "Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease", Circ Res, 116, pp.289~297 (2015)
23. Schmidt-Lucke C, "Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events : proof of concept for the clinical importance of endogenous vascular repair", Circulation, 111, pp.2981~2987 (2005)
24. Werner N, "Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease", Basic Res Cardiol, 102, pp.565~571 (2007)
25. Vasa M, "Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease", Circ Res, 89, pp.E1~E7 (2001)
26. Huang C, "Endothelial progenitor cells are associated with plasma homocysteine in coronary artery disease", Acta Cardiol, 66, pp.773~777 (2011)
27. Vemparala K, "Early accelerated senescence of circulating endothelial progenitor cells in premature coronary artery disease patients in a developing country-a case control study", BMC Cardiovasc Disord, 13, pp.104~ (2013)
28. Hammadah M, "Telomere shortening, regenerative capacity, and cardiovascular outcomes", Circ Res, 120, pp.1130~1138 (2017)
29. Mehta A, "Circulating progenitor cells in patients with coronary artery disease and renal insufficiency", JACC Basic Transl Sci, 5, pp.770~782 (2020)
30. Mehta A, "Vascular regenerative capacity and the obesity paradox in coronary artery disease", Arterioscler Thromb Vasc Biol, 41, pp.2097~2108 (2021)
31. Chong AY, "Endothelial dysfunction and damage in congestive heart failure : relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide", Circulation, 110, pp.1794~1798 (2004)
32. Fischer D, "Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death", Eur Heart J, 26, pp.65~69 (2005)
33. Marti CN, "Endothelial dysfunction, arterial stiffness, and heart failure", J Am Coll Cardiol, 60, pp.1455~1469 (2012)
34. Valgimigli M, "CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure", Circulation, 110, pp.1209~1212 (2004)
35. Nonaka-Sarukawa M, "Circulating endothelial progenitor cells in congestive heart failure", Int J Cardiol, 119, pp.344~348 (2007)
36. Michowitz Y, "Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure", Heart, 93, pp.1046~1050 (2007)
37. Oliveras A, "Endothelial progenitor cells are reduced in refractory hypertension", J Hum Hypertens, 22, pp.183~190 (2008)
38. Fadini GP, "Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population", Stroke, 37, pp.2277~2282 (2006)
39. Jialal I, "Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome : implications for increased cardiovascular risk", Atherosclerosis, 211, pp.297~302 (2010)
40. Egan CG, "Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes", Diabetologia, 51, pp.1296~1305 (2008)
41. Fadini GP, "Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus", J Am Coll Cardiol, 45, pp.1449~1457 (2005)
42. Hill JM, "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk", N Engl J Med, 348, pp.593~600 (2003)
43. Sandri M, "Chronic heart failure and aging-effects of exercise training on endothelial function and mechanisms of endothelial regeneration : results from the Leipzig Exercise Intervention in Chronic heart failure and Aging(LEICA)study", Eur J Prev Cardiol, 23, pp.349~358 (2016)
44. Maiorino MI, "Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes : follow-up of a randomized trial", Eur J Prev Cardiol, 24, pp.399~408 (2017)
45. Yubero-Serrano EM, "Mediterranean diet and endothelial function in patients with coronary heart disease : an analysis of the CORDIOPREV randomized controlled trial", PLoS Med, 17, pp.e1003282~ (2020)
46. Laird E, "Vitamin D and bone health; potential mechanisms", Nutrients, 2, pp.693~724 (2010)
47. Nair R, "Vitamin D : the"sunshine"vitamin", J Pharmacol Pharmacother, 3, pp.118~126 (2012)
48. Al Mheid I, "Vitamin D and cardiovascular disease : controversy unresolved", J Am Coll Cardiol, 70, pp.89~100 (2017)
49. Nitsa A, "Vitamin D in cardiovascular disease", In Vivo, 32, pp.977~981 (2018)
50. Bikle DD, "Endotext" (2000), MDText.com, Inc
51. Chen S, "Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy", Circulation, 124, pp.1838~1847 (2011)
52. Grimes DS, "Sunlight, cholesterol and coronary heart disease", QJM, 89, pp.579~589 (1996)
53. Kendrick J, "25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey", Atherosclerosis, 205, pp.255~260 (2009)
54. Wang TJ, "Vitamin D deficiency and risk of cardiovascular disease", Circulation, 117, pp.503~511 (2008)
55. Giovannucci E, "25-hydroxyvitamin D and risk of myocardial infarction in men : a prospective study", Arch Intern Med, 168, pp.1174~1180 (2008)
56. Hlaing SM, "1, 25-vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway", J Mol Endocrinol, 53, pp.303~317 (2014)
57. Goleniewska B, "Vitamin D level and extent of coronary stenotic lesions in patients with first acute myocardial infarction", Cardiol J, 21, pp.18~23 (2014)
58. Pilz S, "Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography", J Clin Endocrinol Metab, 93, pp.3927~3935 (2008)
59. Zhang R, "Serum 25-hydroxyvitamin D and the risk of cardiovascular disease : dose-response meta-analysis of prospective studies", Am J Clin Nutr, 105, pp.810~819 (2017)
60. Goliasch G, "Markers of bone metabolism in premature myocardial infarction(≤ 40 years of age)", Bone, 48, pp.622~626 (2011)
61. Mathieu C, "Vitamin D and diabetes", Diabetologia, 48, pp.1247~1257 (2005)
62. Liu E, "Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults", J Nutr, 139, pp.329~334 (2009)
63. Scragg R, "Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey", Diabetes Care, 27, pp.2813~2818 (2004)
64. Chonchol M, "25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey", Kidney Int, 71, pp.134~139 (2007)
65. Pittas AG, "The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis", J Clin Endocrinol Metab, 92, pp.2017~2029 (2007)
66. The EURODIAB Substudy 2 Study Group, "Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus", Diabetologia, 42, pp.51~54 (1999)
67. Duprez D, "Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension", Blood Press, 3, pp.389~393 (1994)
68. Kristal-Boneh E, "Association of calcitriol and blood pressure in normotensive men", Hypertension, 30, pp.1289~1294 (1997)
69. Forman JP, "Plasma 25-hydroxyvitamin D levels and risk of incident hypertension", Hypertension, 49, pp.1063~1069 (2007)
70. Sugden JA, "Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels", Diabet Med, 25, pp.320~325 (2008)
71. Pfeifer M, "Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women", J Clin Endocrinol Metab, 86, pp.1633~1637 (2001)
72. Burgess ED, "Interaction of 1, 25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension", Am J Hypertens, 3, pp.903~905 (1990)
73. Li YC, "1, 25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system", J Clin Invest, 110, pp.229~238 (2002)
74. Dong J, "Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress", Eur Heart J, 33, pp.2980~2990 (2012)
75. Rigby WF, "Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA", J Clin Invest, 79, pp.1659~1664 (1987)
76. Canning MO, "1-alpha, 25-Dihydroxyvitamin D3(1, 25(OH)(2)D(3))hampers the maturation of fully active immature dendritic cells from monocytes", Eur J Endocrinol, 145, pp.351~357 (2001)
77. Aihara K, "Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice", J Biol Chem, 279, pp.35798~35802 (2004)
78. Guillot X, "Vitamin D and inflammation", Joint Bone Spine, 77, pp.552~557 (2010)
79. Takeda M, "Oral administration of an active form of vitamin D3(calcitriol)decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions", Arterioscler Thromb Vasc Biol, 30, pp.2495~2503 (2010)
80. Manson JE, "The VITamin D and OmegA-3 TriaL(VITAL) : rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease", Contemp Clin Trials, 33, pp.159~171 (2012)
81. Oh J, "1, 25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus", Circulation, 120, pp.687~698 (2009)
82. Al Mheid I, "Vitamin D and cardiovascular disease : is the evidence solid?", Eur Heart J, 34, pp.3691~3698 (2013)
83. Kunadian V, "Vitamin D deficiency and coronary artery disease : a review of the evidence", Am Heart J, 167, pp.283~291 (2014)
84. Lee JH, "Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?", J Am Coll Cardiol, 52, pp.1949~1956 (2008)
85. Ferder M, "The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system", Am J Physiol Cell Physiol, 304, pp.C1027~ (2013)
86. SchleithoffSS, "Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure : a double-blind, randomized, placebo-controlled trial", Am J Clin Nutr, 83, pp.754~759 (2006)
87. Zhu Y, "Calcium and 1 alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease", Eur J Immunol, 35, pp.217~224 (2005)
88. Canning MO, "1-alpha, 25-dihydroxyvitamin D3(1, 25(OH)(2)D(3))hampers the maturation of fully active immature dendritic cells from monocytes", Eur J Endocrinol, 145, pp.351~357 (2001)
89. Shea MK, "Vitamin K and vitamin D status : associations with inflammatory markers in the Framingham Offspring Study", Am J Epidemiol, 167, pp.313~320 (2008)
90. Hin H, "Optimum dose of vitamin D for disease prevention in older people : BEST-D trial of vitamin D in primary care", Osteoporos Int, 28, pp.841~851 (2017)
91. Arnson Y, "Vitamin D inflammatory cytokines and coronary events : a comprehensive review", Clin Rev Allergy Immunol, 45, pp.236~247 (2013)
92. Sokol SI, "The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease", Vasc Med, 17, pp.394~404 (2012)
93. Scragg R, "Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study : a randomized clinical trial", JAMA Cardiol, 2, pp.608~616 (2017)
94. Manson JE, "Vitamin D supplements and prevention of cancer and cardiovascular disease", N Engl J Med, 380, pp.33~44 (2019)
95. Wu Z, "Effects of vitamin D supplementation as an adjuvant therapy in coronary artery disease patients", Scand Cardiovasc J, 50, pp.9~16 (2016)
96. Molinari C, "1α, 25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells", Cell Physiol Biochem, 27, pp.661~668 (2011)
97. Huang Z, "Vitamin D(1, 25-(OH)2D3)improves endothelial progenitor cells function via enhanced NO secretion in systemic lupus erythematosus", Cardiol Res Pract, 2020, pp.6802562~ (2020)
98. Grundmann M, "Vitamin D improves the angiogenic properties of endothelial progenitor cells", Am J Physiol Cell Physiol, 303, pp.C954~ (2012)
99. Brodowski L, "Vitamin D prevents endothelial progenitor cell dysfunction induced by sera from women with preeclampsia or conditioned media from hypoxic placenta", PLoS One, 9, pp.e98527~ (2014)
100. von Versen-Höynck F, "Vitamin D antagonizes negative effects of preeclampsia on fetal endothelial colony forming cell number and function", PLoS One, 9, pp.e98990~ (2014)
101. Barker DJ, "Maternal and fetal origins of coronary heart disease", J R Coll Physicians Lond, 28, pp.544~551 (1994)
102. Gluckman PD, "Effect of in utero and early-life conditions on adult health and disease", N Engl J Med, 359, pp.61~73 (2008)
103. Bodnar LM, "Maternal vitamin D deficiency increases the risk of preeclampsia", J Clin Endocrinol Metab, 92, pp.3517~3522 (2007)
104. Robinson CJ, "Maternal vitamin D and fetal growth in early-onset severe preeclampsia", Am J Obstet Gynecol, 204, pp.556~ (2011)
105. Sipos PI, "Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal origin", Stem Cells, 31, pp.1363~1370 (2013)
106. Brodowski L, "Role of vitamin D in cell-cell interaction of fetal endothelial progenitor cells and umbilical cord endothelial cells in a preeclampsia-like model", Am J Physiol Cell Physiol, 317, pp.C348~ (2019)
107. Zhong W, "Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells", J Steroid Biochem Mol Biol, 140, pp.56~62 (2014)
108. Uberti F, "Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways", J Clin Endocrinol Metab, 99, pp.1367~1374 (2014)
109. Stach K, "1α, 25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells", Cardiology, 118, pp.107~115 (2011)
110. Brownlee M, "Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications", N Engl J Med, 318, pp.1315~1321 (1988)
111. Makita Z, "Advanced glycosylation end products in patients with diabetic nephropathy", N Engl J Med, 325, pp.836~842 (1991)
112. Vlassara H, "Advanced glycation endproducts promote adhesion molecule(VCAM-1, ICAM-1)expression and atheroma formation in normal rabbits", Mol Med, 1, pp.447~456 (1995)
113. Talmor Y, "Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells", Am J Physiol Renal Physiol, 294, pp.F1059~F1064 (2008)
114. Ambros V, "The functions of animal microRNAs", Nature, 431, pp.350~355 (2004)
115. Farh KK, "The widespread impact of mammalian microRNAs on mRNA repression and evolution", Science, 310, pp.1817~1821 (2005)
116. Zitman-Gal T, "Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment", Cardiovasc Diabetol, 13, pp.8~ (2014)
117. Zitman-Gal T, "Vitamin D receptor activation in a diabetic-like environment : potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways", J Steroid Biochem Mol Biol, 132, pp.1~7 (2012)
118. Marco LJ, "Cardiovascular disease risk in the offspring of diabetic women : the impact of the intrauterine environment", Exp Diabetes Res, 2012, pp.565160~ (2012)
119. Gui J, "Vitamin D rescues dysfunction of fetal endothelial colony forming cells from individuals with gestational diabetes", Placenta, 36, pp.410~418 (2015)
120. Sugden JA, "Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels", Diabet Med, 25, pp.320~325 (2008)
121. Yu P, "Vitamin D(1, 25-(OH)2D3)regulates the gene expression through competing endogenous RNAs networks in high glucose-treated endothelial progenitor cells", J Steroid Biochem Mol Biol, 193, pp.105425~ (2019)
122. Jiang S, "IL-35 inhibits angiogenesis through VEGF", Ang2, Cell Physiol Biochem, pp.2016, 40[DOI]
123. Chen X, "Lanthanum chloride inhibits LPS mediated expressions of pro-inflammatory cytokines and adhesion molecules in HUVECs : involvement of NF-κB-Jmjd3 signaling", Cell Physiol Biochem, 42, pp.1713~1724 (2017)
124. Liang B, "Angiotensin-(1-7)attenuates angiotensin II-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-κB pathways in HUVECs", Cell Physiol Biochem, 35, pp.2472~2482 (2015)
125. Xu W, "Vitamin D ameliorates angiotensin II-induced human endothelial progenitor cell injury via the PPAR-γ", HO-1 pathway, 2019, pp.56, 17~27
126. Xiang W, "Intravenous transfusion of endothelial progenitor cells that overexpress vitamin D receptor inhibits atherosclerosis in ApoE-deficient mice", Biomed Pharmacother, 84, pp.1233~1242 (2016)
127. El-Magadmi M, "Systemic lupus erythematosus : an independent risk factor for endothelial dysfunction in women", Circulation, 110, pp.399~404 (2004)
128. Zeller CB, "Cardiovascular disease in systemic lupus erythematosus : the role of traditional and lupus related risk factors", Curr Cardiol Rev, 4, pp.116~122 (2008)
129. Reynolds JA, "Brief report : vitamin D deficiency is associated with endothelial dysfunction and increases type I interferon gene expression in a murine model of systemic lupus erythematosus", Arthritis Rheumatol, 68, pp.2929~2935 (2016)
130. Heaney RP, "Vitamin D in health and disease", Clin J Am Soc Nephrol, 3, pp.1535~1541 (2008)
131. Omdahl JL, "Hydroxylase enzymes of the vitamin D pathway : expression, function, and regulation", Annu Rev Nutr, 22, pp.139~166 (2002)
132. Rachez C, "Mechanisms of gene regulation by vitamin D(3)receptor : a network of coactivator interactions", Gene, 246, pp.9~21 (2000)
133. Swain LD, "1, 25-(OH)2D3 and 24, 25-(OH)2D3 regulation of arachidonic acid turnover in chondrocyte cultures is cell maturation-specific and may involve direct effects on phospholipase A2", Biochim Biophys Acta, 1136, pp.45~51 (1992)
134. Yiu YF, "Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes", J Clin Endocrinol Metab, 96, pp.E830~E835 (2011)
135. Mikirova NA, "Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors", Panminerva Med, 52, pp.81~87 (2010)
136. Cianciolo G, "VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy", Blood Purif, 32, pp.161~173 (2011)
137. Berezin AE, "Non-classical progenitor mononuclears in metabolic syndrome : the role of serum 25-hydroxyvitamin D3", Clin Med Biochem, 2, pp.1000115~ (2016)
138. Lo Gullo A, "Vitamin D status in rheumatoid arthritis : inflammation, arterial stiffness and circulating progenitor cell number", PLoS One, 10, pp.e0134602~ (2015)
139. Chan YH, "Vascular protective effects of statin-related increase in serum 25-hydroxyvitamin D among high-risk cardiac patients", J Cardiovasc Med(Hagerstown), 16, pp.51~58 (2015)
140. Gurses KM, "Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement", Atherosclerosis, 237, pp.784~789 (2014)
141. Yiu YF, "Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes", Atherosclerosis, 227, pp.140~146 (2013)
142. Pilz S, "Vitamin D and cardiovascular disease prevention", Nat Rev Cardiol, 13, pp.404~417 (2016)

관련 논문AI추천